1Aguayo A, Cortes J, Thomas D, et al. Combination therapy with methotrexate, vincristine, polyethylene glycol conjugated asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia. Cancer, 1999,86:12
2Thiebaut A. Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation a follow up report of the French protocol LALA 87. Hematol Oncol Clin North Am, 2000, 14:1353-1359.
3Doney K, Fisher L D, Applebaum F R, et al. Treatment of adult acute lymphoblastic leukemia with alloge neic bone marrow transplantation: Multivariate analysis of factors affecting graft-versus host disease, relapse,and relapse free survival. Bone marrow t
4Koller C A, Kanterjian H M, Thomas D. et al. The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia, 1997, 11:2039-2045.
5Suki S, Kantarjian H, Gandhi V, et al. Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia. Cancer, 1993,72:2155 - 2169.
6Davies S M, Ramsay N K, Weisdorf D J. Feasibility and timing of unrelated donor identification for patients with All. Bone Marrow Transplant, 1996, 17: 737-743.
7Weisdorf D J, Billett A L, Hannan P, et al. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia . Blood,1997,90:2962-2968.
8Hunautt M, Harousseau J L, Delain M, et al. Improved outcome of high risk acute lymphoblastic leukemia (ALL) with late high dose therapy. A GOELAMS's Trial. Blood,2001,98:803a-803a.
9Hoelzer D, Ludwing W D, Thiel E, et al. Improved outcome in -adult B-cell acute lymphoblastic leukemia.Blood, 1996, 87: 495-508.
10Thomas D A, Cortes J, Giles F J, et al. The modified Hyper-CVAD regimen in newly diagnosed adult acute lymphoblastic leukemia (ALL). Blood. 2001, 98: 590a-590a.
3Tang R,Favssat AM,Majdak P,et al.Semisynthetic homohrringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells.MOL Cancer Ther,2006,5:723-731.
